429 related articles for article (PubMed ID: 38030657)
1. Characterization of cannabinoid plasma concentration, maternal health, and cytokine levels in a rat model of prenatal Cannabis smoke exposure.
Black T; Baccetto SL; Barnard IL; Finch E; McElroy DL; Austin-Scott FVL; Greba Q; Michel D; Zagzoog A; Howland JG; Laprairie RB
Sci Rep; 2023 Nov; 13(1):21070. PubMed ID: 38030657
[TBL] [Abstract][Full Text] [Related]
2. Differential inflammatory profile in the lungs of mice exposed to cannabis smoke with varying THC:CBD ratio.
Haidar Z; Traboulsi H; Eidelman DH; Baglole CJ
Arch Toxicol; 2023 Jul; 97(7):1963-1978. PubMed ID: 37179517
[TBL] [Abstract][Full Text] [Related]
3. Dissociable changes in spike and wave discharges following exposure to injected cannabinoids and smoked cannabis in Genetic Absence Epilepsy Rats from Strasbourg.
Roebuck AJ; Greba Q; Onofrychuk TJ; McElroy DL; Sandini TM; Zagzoog A; Simone J; Cain SM; Snutch TP; Laprairie RB; Howland JG
Eur J Neurosci; 2022 Feb; 55(4):1063-1078. PubMed ID: 33370468
[TBL] [Abstract][Full Text] [Related]
4. Medical Cannabis Use and Inflammatory Cytokines and Chemokines Among Adult Chronic Pain Patients.
Ajrawat P; Yang Y; Wasilewski E; Leroux T; Ladha KS; Bhatia A; Singh M; Thaker S; Kapoor M; Furlan AD; Kotra LP; Clarke H
Cannabis Cannabinoid Res; 2024 Feb; 9(1):267-281. PubMed ID: 36342776
[No Abstract] [Full Text] [Related]
5. Maternal-fetal transmission of delta-9-tetrahydrocannabinol (THC) and its metabolites following inhalation and injection exposure during pregnancy in rats.
Baglot SL; VanRyzin JW; Marquardt AE; Aukema RJ; Petrie GN; Hume C; Reinl EL; Bieber JB; McLaughlin RJ; McCarthy MM; Hill MN
J Neurosci Res; 2022 Mar; 100(3):713-730. PubMed ID: 34882838
[TBL] [Abstract][Full Text] [Related]
6. An assessment of qualitative and quantitative cannabinoids analysis in selected commercially available cannabis oils in Argentina.
Fernández N; Cappello MG; Quiroga PN
Forensic Sci Int; 2023 Aug; 349():111762. PubMed ID: 37392612
[TBL] [Abstract][Full Text] [Related]
7. The effects of acute Cannabis smoke or Δ
Barnard IL; Onofrychuk TJ; Sandini TM; McElroy DL; Zagzoog A; Roebuck AJ; Austin-Scott FV; Laprairie RB; Howland JG
Neurobiol Learn Mem; 2022 Jul; 192():107624. PubMed ID: 35513236
[TBL] [Abstract][Full Text] [Related]
8. Knowledge of Tetrahydrocannabinol and Cannabidiol Levels Among Cannabis Consumers in the United States and Canada.
Hammond D; Goodman S
Cannabis Cannabinoid Res; 2022 Jun; 7(3):345-354. PubMed ID: 33998866
[No Abstract] [Full Text] [Related]
9. Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Plasma Endocannabinoid Levels in Healthy Volunteers: A Randomized Double-Blind Four-Arm Crossover Study.
Chester LA; Englund A; Chesney E; Oliver D; Wilson J; Sovi S; Dickens AM; Oresic M; Linderman T; Hodsoll J; Minichino A; Strang J; Murray RM; Freeman TP; McGuire P
Cannabis Cannabinoid Res; 2024 Feb; 9(1):188-198. PubMed ID: 36493386
[No Abstract] [Full Text] [Related]
10. Differences in prescribed medicinal cannabis use by cannabinoid product composition: Findings from the cannabis as medicine survey 2020 (CAMS-20) Australia-wide study.
Trevitt BT; Bailey S; Mills L; Arkell TR; Suraev A; McGregor IS; Lintzeris N
PLoS One; 2024; 19(2):e0297092. PubMed ID: 38354169
[TBL] [Abstract][Full Text] [Related]
11. Absence of Relevant Thermal Conversion of Cannabidiol to Tetrahydrocannabinol in E-Cigarette Vapor and Low-Tetrahydrocannabinol Cannabis Smoke.
Hindelang P; Scharinger A; Golombek P; Laible M; Tamosaite S; Walch SG; Lachenmeier DW
Cannabis Cannabinoid Res; 2022 Oct; 7(5):616-620. PubMed ID: 36169637
[No Abstract] [Full Text] [Related]
12. Cannabinoid use is enhanced by stress and changes conditioned stress responses.
Hodebourg R; Meyerink ME; Crow AD; Reichel CM; Kalivas PW; Garcia-Keller C
Neuropsychopharmacology; 2022 Apr; 47(5):1037-1045. PubMed ID: 35145212
[TBL] [Abstract][Full Text] [Related]
13. Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids.
Hindelang P; Scharinger A; Richling E; Walch SG; Lachenmeier DW
Front Biosci (Landmark Ed); 2022 Jul; 27(8):228. PubMed ID: 36042166
[TBL] [Abstract][Full Text] [Related]
14. Individual and combined effects of cannabidiol and Δ
Wall MB; Freeman TP; Hindocha C; Demetriou L; Ertl N; Freeman AM; Jones AP; Lawn W; Pope R; Mokrysz C; Solomons D; Statton B; Walker HR; Yamamori Y; Yang Z; Yim JL; Nutt DJ; Howes OD; Curran HV; Bloomfield MA
J Psychopharmacol; 2022 Jun; 36(6):732-744. PubMed ID: 35596578
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of Action and Pharmacokinetics of Cannabis.
Chayasirisobhon S
Perm J; 2020 Dec; 25():1-3. PubMed ID: 33635755
[TBL] [Abstract][Full Text] [Related]
16. Effects of oral Δ9-tetrahydrocannabinol and cannabidiol combinations on a sustained attention task in rats.
Moore CF; Davis CM; Sempio C; Klawitter J; Christians U; Weerts EM
Exp Clin Psychopharmacol; 2023 Oct; 31(5):881-887. PubMed ID: 36634015
[TBL] [Abstract][Full Text] [Related]
17. Acute effects of Δ
Greenwood LM; Broyd SJ; van Hell HH; Todd J; Jones A; Murray RM; Croft RJ; Michie PT; Solowij N
Psychopharmacology (Berl); 2022 May; 239(5):1409-1424. PubMed ID: 34719731
[TBL] [Abstract][Full Text] [Related]
18. Cannabidiol Interferes with Establishment of Δ
DeVuono MV; La Caprara O; Petrie GN; Limebeer CL; Rock EM; Hill MN; Parker LA
Cannabis Cannabinoid Res; 2022 Feb; 7(1):58-64. PubMed ID: 33998876
[No Abstract] [Full Text] [Related]
19. Receptor-mediated effects of Δ
Preteroti MW; Traboulsi H; Greiss P; Lapohos O; Fonseca GJ; Eidelman DH; Baglole CJ
Immunol Cell Biol; 2023 Feb; 101(2):156-170. PubMed ID: 36510483
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations.
Moore CF; Weerts EM
Psychopharmacology (Berl); 2022 May; 239(5):1397-1408. PubMed ID: 34652500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]